BRPI0810171A2 - Método para o aumento da secreção de insulina - Google Patents

Método para o aumento da secreção de insulina

Info

Publication number
BRPI0810171A2
BRPI0810171A2 BRPI0810171-0A2A BRPI0810171A BRPI0810171A2 BR PI0810171 A2 BRPI0810171 A2 BR PI0810171A2 BR PI0810171 A BRPI0810171 A BR PI0810171A BR PI0810171 A2 BRPI0810171 A2 BR PI0810171A2
Authority
BR
Brazil
Prior art keywords
insulin secretion
increasing insulin
increasing
secretion
insulin
Prior art date
Application number
BRPI0810171-0A2A
Other languages
English (en)
Inventor
Orlando De Souza
Luiz Belardinelli
John Shryock
Kwan Leung
Dewan Zeng
Original Assignee
Cv Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cv Therapeutics Inc filed Critical Cv Therapeutics Inc
Publication of BRPI0810171A2 publication Critical patent/BRPI0810171A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0810171-0A2A 2007-04-12 2008-04-11 Método para o aumento da secreção de insulina BRPI0810171A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US91145707P 2007-04-12 2007-04-12
US97700907P 2007-10-02 2007-10-02
US2622308P 2008-02-05 2008-02-05
PCT/US2008/060090 WO2008128086A1 (en) 2007-04-12 2008-04-11 Ranolazine for enhancing insulin secretion

Publications (1)

Publication Number Publication Date
BRPI0810171A2 true BRPI0810171A2 (pt) 2014-12-30

Family

ID=39598448

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0810171-0A2A BRPI0810171A2 (pt) 2007-04-12 2008-04-11 Método para o aumento da secreção de insulina

Country Status (10)

Country Link
US (2) US20080255031A1 (pt)
EP (1) EP2139480A1 (pt)
JP (1) JP2010523713A (pt)
KR (1) KR20100015685A (pt)
AU (1) AU2008240202A1 (pt)
BR (1) BRPI0810171A2 (pt)
CA (1) CA2681444A1 (pt)
IL (1) IL201071A0 (pt)
MX (1) MX2009010895A (pt)
WO (1) WO2008128086A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090012103A1 (en) * 2007-07-05 2009-01-08 Matthew Abelman Substituted heterocyclic compounds
CA2713521A1 (en) * 2008-02-06 2009-08-13 Gilead Palo Alto, Inc. Use of ranolazine for treating pain
US8901128B2 (en) * 2009-05-28 2014-12-02 Lupin Limited Pharmaceutical compositions of ranolazine
US20120177729A1 (en) * 2009-09-25 2012-07-12 Lupin Limited Sustained release composition of ranolazine
CN103153288B (zh) 2010-07-09 2017-02-15 詹姆斯·特林卡·格林 用于包括瑞格列净的短半衰期药物的组合立即/延迟释放递送系统
ES2648820T3 (es) 2011-05-10 2018-01-08 Gilead Sciences, Inc. Compuestos heterocíclicos condensados como moduladores de los canales de sodio
TWI478908B (zh) 2011-07-01 2015-04-01 Gilead Sciences Inc 作為離子通道調節劑之稠合雜環化合物
NO3175985T3 (pt) 2011-07-01 2018-04-28
GR1010510B (el) * 2022-06-07 2023-07-20 Ελπεν Α.Ε. Φαρμακευτικη Βιομηχανια, Στερεες φαρμακοτεχνικες μορφες παρατεταμενης αποδεσμευσης ρανολαζινης
WO2025252860A1 (en) * 2024-06-04 2025-12-11 Celex Oncology Innovations Limited Ranolazine enantiomer for use in cancer treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002007716A2 (en) * 2000-07-21 2002-01-31 Cv Therapeutics, Inc. Method for treating angina
CA2486712C (en) * 2002-05-21 2012-01-03 Cv Therapeutics, Inc. Method of treating diabetes
WO2006074398A2 (en) * 2005-01-06 2006-07-13 Cv Therapeutics, Inc. Sustained release pharmaceutical formulations comprising ranolazine

Also Published As

Publication number Publication date
KR20100015685A (ko) 2010-02-12
US20080255031A1 (en) 2008-10-16
MX2009010895A (es) 2009-10-26
AU2008240202A1 (en) 2008-10-23
JP2010523713A (ja) 2010-07-15
US20100105695A1 (en) 2010-04-29
CA2681444A1 (en) 2008-10-23
IL201071A0 (en) 2010-05-17
WO2008128086A1 (en) 2008-10-23
EP2139480A1 (en) 2010-01-06

Similar Documents

Publication Publication Date Title
NO2024044I1 (no) Insulin icodec
BRPI0910282A2 (pt) Composto oxadiazo-antraceno para o tratamento de diabetes
BRPI0810171A2 (pt) Método para o aumento da secreção de insulina
BRPI0814359A2 (pt) Método
BRPI0817226A2 (pt) Método
BRPI0916152A2 (pt) aparelho para via aérea melhorado
BRPI0817726A2 (pt) Método
BRPI0819127A2 (pt) Método para cimentar.
BRPI0821158A2 (pt) Método para fazer lentes de contato
BRPI0912384A2 (pt) composição, e, método para preparar uma composição
BRPI0812744A2 (pt) Métodos para melhoramento molecular direcionado por sequência
BRPI0911077A2 (pt) método para tratamento de biomassa
BRPI0815550A2 (pt) Método para estabilizar fenilefrina
FI20075721A0 (fi) Menetelmä pyrolysoinnin toteuttamiseksi
BRPI0811786A2 (pt) Acionador para inalador dosimetrado
BRPI0822730A2 (pt) Método para comutação ininterrupta
BR112012007880A2 (pt) aparelho de fabricação para um membro dobrado, método para fabricar um membro dobrado e membro dobrado
BRPI0813670A2 (pt) Compostos para tratamento
BRPI0922490A2 (pt) Método para produção de beta-santaleno
BRPI0906491A2 (pt) Método para reconstrução de imagem.
FI20075505A0 (fi) Menetelmä silmälasien valmistamiseksi
BRPI0813858A2 (pt) Método para produzir peptídeo
BRPI0812741A2 (pt) Método para separação de glóbulos
BRPI0907643A2 (pt) Dispositivo de irrigação, método para fabricar dito dispositivo, e meios por conseguinte
BRPI0810416A2 (pt) Método de hidroformação

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]